Physician
Hematology
Dr. Solomon Zimm, MD
|
|
Give Review
Solomon Zimm is an expert in the field of Hematology. He went to medical school at Virginia Commonwealth University School of Medicine. He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Solomon Zimm is a published physician. He has 33 publications published. The most current publication "Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group..." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk Acute lymphoblastic leukemia: a joint children's cancer group...
- Response of metastatic cloacogenic Carcinoma to treatment with semustine.
- Intracerebral metastases in solid-tumor patients: natural history and results of treatment.
- Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
- Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion.
- Cytosine arabinoside cerebrospinal fluid kinetics.
- Inhibition of first-pass metabolism in Cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol.
- Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in Acute lymphoblastic leukemia being optimally delivered?
- Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey.
- The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss.
- Addison's disease as the sole clinical manifestation of recurrent bronchogenic Carcinoma.
- Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion.
- Pediatric phase I trial and pharmacokinetic study of tiazofurin (NSC 286193).
- Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.
- The effect of amitriptyline on the central Nervous system penetration of methotrexate.
- A clinically useful ion-pairing high-performance liquid chromatographic assay for the monophosphate metabolites of thioguanine and mercaptopurine in human neoplastic c...
- The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.
- Modulation of thiopurine cytotoxicity in the HL-60 Cell line by physiological concentrations of hypoxanthine.
- The pharmacology of orally administered chemotherapy. A reappraisal.
- Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusion.
- Pharmacokinetics of intraperitoneally administered dipyridamole in Cancer patients.
- Intraperitoneal chemotherapy: application to upper gastrointestinal Neoplasms.
- Pediatric phase I trial and pharmacokinetic study of trimetrexate.
- Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
- Long-term survival of advanced refractory ovarian Carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.
- Biochemical parameters of mercaptopurine activity in patients with Acute lymphoblastic leukemia.
- Cellular pharmacokinetics of mercaptopurine in human neoplastic Cells and Cell lines.
- Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
- A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial Cancer.
- A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid Tumors.
- Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
- A phase II trial of continuous-infusion 6-mercaptopurine for childhood Leukemia.
Schools
Virginia Commonwealth University Medical College Of Virginia School Of Medicine
Med College Of Virginia Hospital
National Canc Institute
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Virginia Commonwealth University Health System -
Virginia Commonwealth University School of Medicine
Drug Facts
| NPI NUMBER | 1497717938 | |
| NPPES Provider LastName | ZIMM | |
| NPPES Provider FirstName | SOLOMON | |
| NPPES Provider ZIPCode | 327962871 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 856.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 94.0 | |
| Percent Opioid Claims | 10.98 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497717938 |
| Last Name Of The Provider | ZIMM |
| First Name Of The Provider | SOLOMON |
| View All |
Similar Doctors
|
|
Dr. Firas R. Muwalla, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel R. Pelayo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard D. Sprawls, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Levine, MD |
|
|
Dr. Ashish V. Dalal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan L. Castro, MD |